新型醛固酮与肾素免疫分析的分析评估及生物临床验证
研究评估了Lumipulse G600II系统上新型醛固酮和肾素免疫分析的分析性能,并与iSYS系统进行比较。结果显示两种分析的精密度CV分别小于3%和6%,线性优良,与iSYS系统强相关(R2=1)但存在轻微低估,且基于诊断标准得到相同临床诊断。EDTA血浆、肝素血浆和血清之间相关性良好。结论认为该分析适用于常规使用,但建议肾素标准化至WHO国际标准。
要点
- Lumipulse G醛固酮和肾素分析的精密度CV分别小于3%和6%。
- 与iSYS系统比较R2=1,但醛固酮和肾素存在轻微低估。
- 两种系统基于诊断标准得出相同临床诊断,样本类型间相关性良好。
核心结论
- Lumipulse G醛固酮和肾素分析性能适合医学实验室常规使用。
- 低范围精确定量可能对站位/卧位试验等临床情境有价值。
- 建议肾素针对WHO国际标准进行标准化。
研究设计与样本
- 使用Lumipulse G醛固酮和肾素分析进行不精密度研究、线性和方法比较(n=107)。
- 使用WHO国际标准(WHO IS 68/356)测试肾素分析的准确性。
- 评估不同样本类型的等效性(n=29)。
- 与iSYS系统比较(n=79)。
主要发现
- Lumipulse G醛固酮和肾素分析的CV分别小于3%和6%。
- 在临床范围内线性优良。
- 与iSYS分析比较R2=1,但醛固酮偏倚为-17.53 pg/mL或48.56 pmol/L,肾素偏倚为-15.395 pg/mL。
- 基于诊断标准的列联表研究显示Lumipulse G结果导致与iSYS结果相同的临床诊断。
- EDTA血浆与肝素血浆以及血清在所有测量范围内均显示清晰相关性。
关键数值与推荐
- 不精密度:Lumipulse G醛固酮CV小于3%,肾素CV小于6%。
- 方法比较:与iSYS系统R2=1,醛固酮偏倚-17.53 pg/mL或48.56 pmol/L,肾素偏倚-15.395 pg/mL。
临床怎么用
- 该分析可用于疑似或确诊原发性醛固酮增多症患者的常规检测。
- 低范围精确定量可能有助于站位/卧位试验等临床情境。
- 建议肾素标准化至WHO国际标准以确保结果可比性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Aldosterone and renin determinations play an important role in the etiological diagnosis of secondary hypertension. The analytical performances of new aldosterone and renin immunoassays on the Lumipulse G600II® system (Fujierbio) were investigated and compared with those of the iSYS® system (IDS) on patients concerned by medical investigations in a context of suspected or proven Primary aldosteronism. METHODS: By using the Lumipulse® G Aldosterone and Renin assays we performed imprecision study, linearity and method comparison (n=107). Accuracy of this new renin assay was tested using the International Standard (WHO IS 68/356). We also assessed the equivalence of the different samples types (n=29). RESULTS: The imprecision evaluation showed all CVs <3% and <6% for Lumipulse® G Aldosterone and Renin assays respectively. The linearity was excellent over the clinical range and the comparison with the iSYS® assays (n=79) showed a strong correlation (R2=1) despite a slight tendency to underestimation (bias of -17.53 pg/mL or 48.56 pmol/L for aldosterone and -15.395 pg/mL for renin). Moreover, the contingency studies based on diagnostic criteria showed that Lumipulse® G results lead to the same clinical diagnosis that iSYS® results. A clear correlation was obtained between EDTA and heparin plasma as well as with the serum for all range of measures. CONCLUSIONS: The Lumipulse® G Aldosterone and Renin assays present performances compatible with a routine use in medical laboratories. The precise quantification in the low range can be of interest in some clinical contexts especially standing/laying tests. However, the standardisation against the WHO International Standard Renin would be advisable.
引用
- Coulon C, Lotierzo M, Fesler P, et al. Analytical evaluation and bioclinical validation of new aldosterone and renin immunoassays. Clin Chem Lab Med. 2022. PMID: 36096492. doi:10.1515/cclm-2022-0576
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。